Phase
Condition
Breast Cancer
Cancer
Treatment
N/AClinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
DISEASE CHARACTERISTICS:
- Diagnosis of 1 of the following:
- Noninvasive ductal carcinoma in situ
- Localized breast cancer
- Stage 0-IIIB disease
- Locally recurrent breast cancer that is post-treatment AND disease-free for ≥ 2years
- Experiencing ≥ 3 hot flashes per day (≥ 21 per week), defined by sweating, flushing,sensation of warmth, night sweats, and/or rapid heart beat of sufficient severity thatthe patient desires therapeutic intervention
- Normal mammogram within the past 10 months
- Hormone receptor status:
- Not specified INCLUSION CRITERIA: Age
- 18 and over Sex
- Female Menopausal status
- Post-menopausal (i.e., no menstrual periods ≥ 12 months or surgical menopause) Performance status
- ECOG 0-2 Life expectancy
- Not specified Hematopoietic
- Not specified Hepatic
- Bilirubin < 2 mg/dL
- SGOT ≤ 2 times normal Renal
- Not specified
Exclusion
EXCLUSION CRITERIA:
- Not pregnant or nursing
- Fertile patients must use effective contraception
- No history of intolerance to St. John's wort PRIOR CONCURRENT THERAPY: Biologic therapy
- Not specified Chemotherapy
- No concurrent cytotoxic chemotherapy Endocrine therapy
- No concurrent selective estrogen-receptor modulators or aromatase inhibitors (e.g.,anastrozole, letrozole, or exemestane) allowed
- Concurrent tamoxifen allowed
- No concurrent estrogen, progestational agents, or androgens for the alleviation of hotflashes
- No concurrent corticosteroids Radiotherapy
- Not specified Surgery
- Not specified Other
- More than 14 days since prior Hypericum perforatum (St. John's wort), monoamineoxidase inhibitors, selective serotonin reuptake inhibitors (e.g., sertraline,paroxetine, or fluoxetine) or selective norepinephrine reuptake inhibitors (e.g.,venlafaxine)
- No concurrent use of any of the following:
- Antidepressants
- Theophylline
- Warfarin, unless for central line prophylaxis
- Protease inhibitors for AIDS
- Digoxin
- Cyclosporine
- Benzodiazepines (e.g., diazepam or alprazolam)
- Calcium-channel blockers (e.g., diltiazem or nifedipine)
- Coenzyme A reductase inhibitors for serum cholesterol reduction
- Macrolide antibiotics (e.g., azithromycin, erythromycin, or clarithromycin)
- Griseofulvin
- Phenobarbital
- Phenytoin
- Rifampin
- Rifabutin
- Grapefruit juice
- Other naturopathic or herbal products
- Ketoconazole
- Fluconazole
- Itraconazole
- Rifabutin
- No other concurrent medications for the alleviation of hot flashes (e.g., clonidine orbellamine)
Study Design
Study Description
Connect with a study center
Helen F. Graham Cancer Center at Christiana Hospital
Newark, Delaware 19713
United StatesSite Not Available
MBCCOP - Howard University Cancer Center
Washington, District of Columbia 20060
United StatesSite Not Available
University of Miami Sylvester Comprehensive Cancer Center - Miami
Miami, Florida 33136
United StatesSite Not Available
CCOP - Central Illinois
Decatur, Illinois 62526
United StatesSite Not Available
CCOP - Northern Indiana CR Consortium
South Bend, Indiana 46601
United StatesSite Not Available
Feist-Weiller Cancer Center at Louisiana State University Health Sciences
Shreveport, Louisiana 71130-3932
United StatesSite Not Available
CCOP - Michigan Cancer Research Consortium
Ann Arbor, Michigan 48106
United StatesSite Not Available
CCOP - Beaumont
Royal Oak, Michigan 48073-6769
United StatesSite Not Available
CCOP - Metro-Minnesota
Saint Louis Park, Minnesota 55416
United StatesSite Not Available
CCOP - Metro-Minnesota
St. Louis Park, Minnesota 55416
United StatesSite Not Available
CCOP - St. Louis-Cape Girardeau
Saint Louis, Missouri 63141
United StatesSite Not Available
Cancer Research for the Ozarks
Springfield, Missouri 65804
United StatesSite Not Available
CCOP - St. Louis-Cape Girardeau
St. Louis, Missouri 63141
United StatesSite Not Available
Alamance Cancer Center at Alamance Regional Medical Center
Burlington, North Carolina 27216
United StatesSite Not Available
Hugh Chatham Memorial Hospital
Elkin, North Carolina 28621
United StatesSite Not Available
CCOP - Southeast Cancer Control Consortium
Goldsboro, North Carolina 27534-9479
United StatesSite Not Available
Leo W. Jenkins Cancer Center at ECU Medical School
Greenville, North Carolina 27835-6028
United StatesSite Not Available
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina 27157-1096
United StatesSite Not Available
CCOP - Greenville
Greenville, South Carolina 29615
United StatesSite Not Available
South Carolina Cancer Specialists
Hilton Head Island, South Carolina 29925
United StatesSite Not Available
CCOP - Upstate Carolina
Spartanburg, South Carolina 29303
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.